Diabetes

diabetes cat

Senior man with diabetes using glucometer to check blood sugar level at home

Key learning points: diabetes in older people with frailty

2019-09-20T08:17:00+01:00By Professor Alan Sinclair

Professor Alan Sinclair explains how care should be personalised and targets adapted for older people with diabetes, including an assessment of frailty

Diabetes equipment 640x426

Type 2 diabetes: the role of the practice pharmacist

2019-02-22T13:58:00+00:00By

Muhammad Siddiqur Rahman highlights the integral role of practice-based pharmacists in managing type 2 diabetes

insulin_resistace_SPL

Co-morbidities in type 2 diabetes

2018-07-05T11:00:00+01:00By

Dr Kevin Fernando describes eight common co-morbidities in patients with type 2 diabetes and how the co-existing conditions should be managed

Dr Kevin Fernando

Type 2 diabetes: what are the benefits and risks of glucose-lowering agents?

2018-02-22T11:00:00+00:00By

Dr Kevin Fernando explains how SIGN 154 offers evidence-based guidance on glucose control therapies for people with type 2 diabetes

Diabetes finger prick (cropped) 250x165

Top tips: type 2 diabetes

2017-06-24T13:00:00+01:00By

Dr Kevin Fernando provides top tips on diagnosing and managing type 2 diabetes and identifying people at high risk

More articles on diabetes

Educational resources

Biosimilar insulin WPG

Guideline for the managed introduction of biosimilar basal insulin

2019-10-09T14:58:00+01:00Supported by an educational grant from Mylan

Guidelines identified a need for clinical guidance in a specific area and approached Mylan for an educational grant to support the development of a working party guideline. This working party guideline was developed by Guidelines, and the Chair and members of the group were chosen by and convened by ...

20190814 Ozempic FDG v11 digital thumbnail

Formulary decision guide: Ozempic®▼ (semaglutide)

2019-08-19T13:22:00+01:00Commissioned by Novo Nordisk Limited

Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Novo Nordisk in a format developed by Guidelines in Practice. It has been reviewed by Novo Nordisk, who commissioned the development of the formulary decision guide.

Management of hyperglycaemia in T2D (animation)

Management of hyperglycaemia in type 2 diabetes, 2018: ADA/EASD consensus report

2019-04-09T09:38:00+01:00Commissioned by Napp Pharmaceuticals Limited

Watch this short animation, commissioned by Napp Pharmaceuticals Limited, to find out about the third joint consensus report on the management of hyperglycaemia in type 2 diabetes by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Final version - Semglee FDG_reprint

Semglee® ▼ (insulin glargine biosimilar)

2019-01-07T08:39:00+00:00Commissioned by Mylan

This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice.

Related Guidelines summaries

  • Guideline for the managed introduction of biosimilar basal insulin

    Wed, 09 Oct 2019 15:02 GMT

    This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.

  • NICE type 2 diabetes guideline

    Tue, 03 Sep 2019 00:00 GMT

    This summary provides recommendations on blood glucose targets, patient education, and includes a useful algorithm on blood glucose management

  • Type 2 diabetes treatment pathway comparison

    Tue, 19 Mar 2019 08:57 GMT

    This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN.

  • Type 2 diabetes: frailty in older people

    Fri, 15 Mar 2019 16:43 GMT

    Summary covers glycaemic targets for older people, priorities for improving high-quality diabetes care, and a useful frailty assessment pathway.

  • NICE pancreatitis guideline

    Tue, 05 Feb 2019 12:19 GMT

    Summary of NICE guidance on pancreatitis covers managing complications, nutrition support, and referral for specialist treatment.